ArticleOncoTargets and therapy2021

Successful Use of Nivolumab in a Patient with Head and Neck Cancer After Allogeneic Bone Marrow Transplantation.

Xiaopei Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.